Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation

Johansson, H., Guerrieri-Gonzaga, A., Gandini, S., Bertelsen, B.-E., Macis, D., Serrano, D., Mellgren, G., Lazzeroni, M., Thomas, P. S., Crew, K. D., Kumar, N. B., Briata, I. M., Galimberti, V., Viale, G., Vornik, L. A., Aristarco, V., Buttiron Webber, T., Spinaci, S., Brown, P. H., … DeCensi, A. (2024). Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation. Npj Breast Cancer, 10(1). https://doi.org/10.1038/s41523-024-00616-8
Authors:
Harriet Johansson
Aliana Guerrieri‐Gonzaga
Sara Gandini
Bjørn-Erik Bertelsen
Debora Macis
Davide Serrano
Gunnar Mellgren
Matteo Lazzeroni
Parijatham S. Thomas
Katherine D. Crew
Nagi B. Kumar
Irene Maria Briata
Viviana Galimberti
Giuseppe Viale
Lana A. Vornik
Valentina Aristarco
Tania Buttiron Webber
Stefano Spinaci
Powel H. Brown
Brandy M. Heckman‐Stoddard
Éva Szabó
Bernardo Bonanni
Andrea DeCensi
Affiliated Authors:
Katherine D. Crew
Publication Type:
Article
Unique ID:
10.1038/s41523-024-00616-8
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: